Logo image of EMN

EASTMAN CHEMICAL CO (EMN) Stock Fundamental Analysis

USA - NYSE:EMN - US2774321002 - Common Stock

63.6 USD
+0.9 (+1.44%)
Last: 10/27/2025, 12:56:33 PM
Fundamental Rating

5

Overall EMN gets a fundamental rating of 5 out of 10. We evaluated EMN against 82 industry peers in the Chemicals industry. EMN has an excellent profitability rating, but there are some minor concerns on its financial health. EMN has a bad growth rate and is valued cheaply. Finally EMN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year EMN was profitable.
In the past year EMN had a positive cash flow from operations.
EMN had positive earnings in each of the past 5 years.
In the past 5 years EMN always reported a positive cash flow from operatings.
EMN Yearly Net Income VS EBIT VS OCF VS FCFEMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.47%, EMN belongs to the top of the industry, outperforming 82.93% of the companies in the same industry.
EMN has a better Return On Equity (14.26%) than 84.15% of its industry peers.
The Return On Invested Capital of EMN (8.30%) is better than 76.83% of its industry peers.
EMN had an Average Return On Invested Capital over the past 3 years of 8.36%. This is above the industry average of 6.30%.
Industry RankSector Rank
ROA 5.47%
ROE 14.26%
ROIC 8.3%
ROA(3y)5.82%
ROA(5y)5.19%
ROE(3y)15.81%
ROE(5y)14.08%
ROIC(3y)8.36%
ROIC(5y)8.64%
EMN Yearly ROA, ROE, ROICEMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

EMN's Profit Margin of 8.96% is amongst the best of the industry. EMN outperforms 84.15% of its industry peers.
EMN's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 14.14%, EMN is doing good in the industry, outperforming 73.17% of the companies in the same industry.
In the last couple of years the Operating Margin of EMN has remained more or less at the same level.
EMN has a Gross Margin of 24.04%. This is comparable to the rest of the industry: EMN outperforms 43.90% of its industry peers.
In the last couple of years the Gross Margin of EMN has remained more or less at the same level.
Industry RankSector Rank
OM 14.14%
PM (TTM) 8.96%
GM 24.04%
OM growth 3Y-7.23%
OM growth 5Y1.24%
PM growth 3Y5.65%
PM growth 5Y3.34%
GM growth 3Y0.75%
GM growth 5Y0.26%
EMN Yearly Profit, Operating, Gross MarginsEMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EMN is still creating some value.
EMN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, EMN has less shares outstanding
The debt/assets ratio for EMN has been reduced compared to a year ago.
EMN Yearly Shares OutstandingEMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
EMN Yearly Total Debt VS Total AssetsEMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.42 indicates that EMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.42, EMN is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
The Debt to FCF ratio of EMN is 12.63, which is on the high side as it means it would take EMN, 12.63 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 12.63, EMN perfoms like the industry average, outperforming 57.32% of the companies in the same industry.
EMN has a Debt/Equity ratio of 0.88. This is a neutral value indicating EMN is somewhat dependend on debt financing.
EMN has a Debt to Equity ratio of 0.88. This is comparable to the rest of the industry: EMN outperforms 40.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 12.63
Altman-Z 2.42
ROIC/WACC1.04
WACC7.97%
EMN Yearly LT Debt VS Equity VS FCFEMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

EMN has a Current Ratio of 1.68. This is a normal value and indicates that EMN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.68, EMN is doing worse than 63.41% of the companies in the same industry.
EMN has a Quick Ratio of 1.68. This is a bad value and indicates that EMN is not financially healthy enough and could expect problems in meeting its short term obligations.
EMN's Quick ratio of 0.78 is on the low side compared to the rest of the industry. EMN is outperformed by 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 0.78
EMN Yearly Current Assets VS Current LiabilitesEMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.82% over the past year.
EMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.08% yearly.
The Revenue has been growing slightly by 1.52% in the past year.
The Revenue has been growing slightly by 0.23% on average over the past years.
EPS 1Y (TTM)16.82%
EPS 3Y-3.79%
EPS 5Y2.08%
EPS Q2Q%-25.58%
Revenue 1Y (TTM)1.52%
Revenue growth 3Y-3.61%
Revenue growth 5Y0.23%
Sales Q2Q%-3.22%

3.2 Future

The Earnings Per Share is expected to grow by 3.03% on average over the next years.
EMN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.24% yearly.
EPS Next Y-26.1%
EPS Next 2Y-6.91%
EPS Next 3Y0.39%
EPS Next 5Y3.03%
Revenue Next Year-4.37%
Revenue Next 2Y-1.16%
Revenue Next 3Y0.36%
Revenue Next 5Y-0.24%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EMN Yearly Revenue VS EstimatesEMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
EMN Yearly EPS VS EstimatesEMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.32, which indicates a very decent valuation of EMN.
EMN's Price/Earnings ratio is rather cheap when compared to the industry. EMN is cheaper than 89.02% of the companies in the same industry.
When comparing the Price/Earnings ratio of EMN to the average of the S&P500 Index (26.89), we can say EMN is valued rather cheaply.
A Price/Forward Earnings ratio of 9.30 indicates a reasonable valuation of EMN.
89.02% of the companies in the same industry are more expensive than EMN, based on the Price/Forward Earnings ratio.
EMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.99.
Industry RankSector Rank
PE 8.32
Fwd PE 9.3
EMN Price Earnings VS Forward Price EarningsEMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EMN is valued cheaper than 86.59% of the companies in the same industry.
EMN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EMN is cheaper than 71.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.99
EV/EBITDA 6.34
EMN Per share dataEMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The decent profitability rating of EMN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.01
EPS Next 2Y-6.91%
EPS Next 3Y0.39%

8

5. Dividend

5.1 Amount

EMN has a Yearly Dividend Yield of 5.26%, which is a nice return.
Compared to an average industry Dividend Yield of 3.69, EMN pays a better dividend. On top of this EMN pays more dividend than 85.37% of the companies listed in the same industry.
EMN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.31.
Industry RankSector Rank
Dividend Yield 5.26%

5.2 History

The dividend of EMN has a limited annual growth rate of 5.58%.
EMN has been paying a dividend for at least 10 years, so it has a reliable track record.
EMN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)5.58%
Div Incr Years15
Div Non Decr Years30
EMN Yearly Dividends per shareEMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

EMN pays out 45.67% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EMN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP45.67%
EPS Next 2Y-6.91%
EPS Next 3Y0.39%
EMN Yearly Income VS Free CF VS DividendEMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
EMN Dividend Payout.EMN Dividend Payout, showing the Payout Ratio.EMN Dividend Payout.PayoutRetained Earnings

EASTMAN CHEMICAL CO

NYSE:EMN (10/27/2025, 12:56:33 PM)

63.6

+0.9 (+1.44%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners91.73%
Inst Owner Change0.73%
Ins Owners0.69%
Ins Owner Change2.37%
Market Cap7.30B
Revenue(TTM)9.29B
Net Income(TTM)832.00M
Analysts76.52
Price Target78.32 (23.14%)
Short Float %3.56%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield 5.26%
Yearly Dividend3.26
Dividend Growth(5Y)5.58%
DP45.67%
Div Incr Years15
Div Non Decr Years30
Ex-Date09-15 2025-09-15 (0.83)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.17%
Min EPS beat(2)-8.32%
Max EPS beat(2)-0.03%
EPS beat(4)2
Avg EPS beat(4)3.58%
Min EPS beat(4)-8.32%
Max EPS beat(4)18.25%
EPS beat(8)6
Avg EPS beat(8)4.04%
EPS beat(12)9
Avg EPS beat(12)2.89%
EPS beat(16)10
Avg EPS beat(16)1.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.09%
Min Revenue beat(2)-2.55%
Max Revenue beat(2)-1.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-2.55%
Max Revenue beat(4)2.62%
Revenue beat(8)1
Avg Revenue beat(8)-1.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.84%
Revenue beat(16)5
Avg Revenue beat(16)0%
PT rev (1m)0.77%
PT rev (3m)-19.92%
EPS NQ rev (1m)-5.48%
EPS NQ rev (3m)-39.03%
EPS NY rev (1m)-2.49%
EPS NY rev (3m)-20.8%
Revenue NQ rev (1m)-0.74%
Revenue NQ rev (3m)-6.81%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)-3.03%
Valuation
Industry RankSector Rank
PE 8.32
Fwd PE 9.3
P/S 0.79
P/FCF 17.99
P/OCF 7.29
P/B 1.25
P/tB 6.4
EV/EBITDA 6.34
EPS(TTM)7.64
EY12.01%
EPS(NY)6.84
Fwd EY10.75%
FCF(TTM)3.54
FCFY5.56%
OCF(TTM)8.73
OCFY13.72%
SpS80.87
BVpS50.81
TBVpS9.95
PEG (NY)N/A
PEG (5Y)4.01
Graham Number93.46
Profitability
Industry RankSector Rank
ROA 5.47%
ROE 14.26%
ROCE 10.23%
ROIC 8.3%
ROICexc 8.58%
ROICexgc 13.57%
OM 14.14%
PM (TTM) 8.96%
GM 24.04%
FCFM 4.37%
ROA(3y)5.82%
ROA(5y)5.19%
ROE(3y)15.81%
ROE(5y)14.08%
ROIC(3y)8.36%
ROIC(5y)8.64%
ROICexc(3y)8.83%
ROICexc(5y)9.06%
ROICexgc(3y)15.26%
ROICexgc(5y)15.76%
ROCE(3y)10.04%
ROCE(5y)10.38%
ROICexgc growth 3Y-10.23%
ROICexgc growth 5Y3.54%
ROICexc growth 3Y-9.52%
ROICexc growth 5Y5.53%
OM growth 3Y-7.23%
OM growth 5Y1.24%
PM growth 3Y5.65%
PM growth 5Y3.34%
GM growth 3Y0.75%
GM growth 5Y0.26%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 12.63
Debt/EBITDA 2.81
Cap/Depr 117.09%
Cap/Sales 6.42%
Interest Coverage 250
Cash Conversion 54.99%
Profit Quality 48.8%
Current Ratio 1.68
Quick Ratio 0.78
Altman-Z 2.42
F-Score6
WACC7.97%
ROIC/WACC1.04
Cap/Depr(3y)138.26%
Cap/Depr(5y)116.93%
Cap/Sales(3y)7.09%
Cap/Sales(5y)6.22%
Profit Quality(3y)60.45%
Profit Quality(5y)105.96%
High Growth Momentum
Growth
EPS 1Y (TTM)16.82%
EPS 3Y-3.79%
EPS 5Y2.08%
EPS Q2Q%-25.58%
EPS Next Y-26.1%
EPS Next 2Y-6.91%
EPS Next 3Y0.39%
EPS Next 5Y3.03%
Revenue 1Y (TTM)1.52%
Revenue growth 3Y-3.61%
Revenue growth 5Y0.23%
Sales Q2Q%-3.22%
Revenue Next Year-4.37%
Revenue Next 2Y-1.16%
Revenue Next 3Y0.36%
Revenue Next 5Y-0.24%
EBIT growth 1Y26.86%
EBIT growth 3Y-10.58%
EBIT growth 5Y1.48%
EBIT Next Year25.43%
EBIT Next 3Y14.32%
EBIT Next 5Y11.73%
FCF growth 1Y21.56%
FCF growth 3Y-13.53%
FCF growth 5Y-8.61%
OCF growth 1Y-10.62%
OCF growth 3Y-7.36%
OCF growth 5Y-3.07%

EASTMAN CHEMICAL CO / EMN FAQ

Can you provide the ChartMill fundamental rating for EASTMAN CHEMICAL CO?

ChartMill assigns a fundamental rating of 5 / 10 to EMN.


What is the valuation status of EASTMAN CHEMICAL CO (EMN) stock?

ChartMill assigns a valuation rating of 7 / 10 to EASTMAN CHEMICAL CO (EMN). This can be considered as Undervalued.


What is the profitability of EMN stock?

EASTMAN CHEMICAL CO (EMN) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EMN stock?

The Price/Earnings (PE) ratio for EASTMAN CHEMICAL CO (EMN) is 8.32 and the Price/Book (PB) ratio is 1.25.


What is the financial health of EASTMAN CHEMICAL CO (EMN) stock?

The financial health rating of EASTMAN CHEMICAL CO (EMN) is 4 / 10.